Fallon sells SHPG 166: Shire Adds to Rare Disease Portfolio with Acquisition of Lumena Pharmaceuticals, Bringing Late Stage Compounds for Rare GI/Hepat ...
Shire plc (LSE: SHP, NASDAQ: SHPG) and Lumena Pharmaceuticals, Inc., a biopharmaceutical company with rare disease pipeline assets, announce the acquisition of Lumena Pharmaceuticals by Shire. Chief Executive of Shire, Flemming Ornskov, MD comments ... ...
40 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home